Elevated serum creatine kinase predicts first-ever myocardial infarction: a 12-year population-based cohort study in

Makoto Watanabe1, Tomonori Okamura, Yoshihiro Kokubo

  • 1Department of Preventive Cardiology, National Cardiovascular Center, Osaka, Japan. makotow@hsp.ncvc.go.jp

Insights

Elevated serum creatine kinase (s-CK) levels can predict future myocardial infarction (MI) in healthy individuals. This risk is particularly high for those with hypercholesterolemia, suggesting s-CK screening is valuable.

Area of Science:

  • Cardiovascular Medicine
  • Biomarker Research
  • Preventive Cardiology

Background:

  • Serum creatine kinase (s-CK) is known to rise post-myocardial infarction (MI).
  • The predictive value of pre-MI s-CK levels for incident MI or stroke remains unclear.
  • This study investigated elevated s-CK as a predictor for first-ever MI and stroke.

Purpose of the Study:

  • To determine if elevated serum creatine kinase (s-CK) predicts first-ever myocardial infarction (MI) or stroke.
  • To explore the relationship between s-CK levels and the risk of cardiovascular events in an initially healthy population.

Main Methods:

  • Population-based cohort study conducted in a Japanese urban area.
  • Included 5026 initially healthy Japanese individuals (2370 men, 2656 women; mean age 54.5 years) with no prior history of MI or stroke.
  • Average follow-up of 11.8 years, observing 103 MIs and 168 strokes.

Main Results:

  • Elevated s-CK levels (≥200 IU/l) were associated with a 4.18-fold increased hazard ratio for definite MI compared to lower levels (
  • No significant association was found between s-CK levels and the risk of stroke.
  • A significant interaction between s-CK levels and hypercholesterolemia was observed for definite MI, with risk linearly increasing with s-CK in hypercholesterolemic subjects.

Conclusions:

  • Screening for elevated serum creatine kinase (s-CK) levels in healthy Japanese individuals can be a useful tool for predicting future first-ever myocardial infarction (MI).
  • The predictive value of elevated s-CK for MI is particularly pronounced in individuals with co-existing dyslipidemia, specifically hypercholesterolemia.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...